Literature DB >> 14648584

Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system.

Jessica Gardner1, Anuja Ghorpade.   

Abstract

Astrocytes are intimately involved in the mechanisms of neural injury and repair. They participate in a variety of homeostatic functions and elicit repair responses as balance mechanisms. Currently, there is a growing appreciation of a more active role of astrocytes in neuronal signaling and function. One key homeostatic mechanism of astrocytes in tissue repair is maintained through their production of tissue inhibitors of metalloproteinases (TIMPs). The family of TIMPs (1-4) plays a central regulatory role as inhibitors of matrix metalloproteinases (MMPs), enzymes involved in extracellular matrix maintenance and remodeling. Recently, TIMP-1, the inducible form, has been identified as a multifunctional molecule with divergent functions. It participates in wound healing and regeneration, cell morphology and survival, tumor metastasis, angiogenesis, and inflammatory responses. An imbalance of MMP/TIMP regulation has been implicated in several inflammatory diseases of the central nervous system (CNS). Here we review the conundrums of TIMP-1 regulation in CNS pathophysiology. We propose that astrocyte-TIMP-1 may play an important role in CNS homeostasis and disease. Astrocyte TIMP-1 expression is differentially regulated in inflammatory neurodegenerative diseases and may have significant therapeutic relevance. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648584      PMCID: PMC3857704          DOI: 10.1002/jnr.10835

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  40 in total

Review 1.  Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications.

Authors:  F Mannello; G Gazzanelli
Journal:  Apoptosis       Date:  2001-12       Impact factor: 4.677

Review 2.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 3.  Human endothelial gelatinases and angiogenesis.

Authors:  M Nguyen; J Arkell; C J Jackson
Journal:  Int J Biochem Cell Biol       Date:  2001-10       Impact factor: 5.085

Review 4.  Astrocyte responses to CNS injury.

Authors:  M D Norenberg
Journal:  J Neuropathol Exp Neurol       Date:  1994-05       Impact factor: 3.685

5.  Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.

Authors:  Frank R Murphy; Razao Issa; Xiaoying Zhou; Shabna Ratnarajah; Hideaki Nagase; Michael J P Arthur; Christopher Benyon; John P Iredale
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

6.  Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia.

Authors:  Santiago Rivera; Crystel Ogier; Jérôme Jourquin; Serge Timsit; Arkadius W Szklarczyk; Karen Miller; Andrew J H Gearing; Leszek Kaczmarek; Michel Khrestchatisky
Journal:  Eur J Neurosci       Date:  2002-01       Impact factor: 3.386

7.  In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture.

Authors:  Megumi Takahashi; Shinjiro Fukami; Nobuhisa Iwata; Keiichi Inoue; Shigeyoshi Itohara; Hiroshi Itoh; Jo Haraoka; Takaomi Saido
Journal:  Pharmacol Res       Date:  2002-08       Impact factor: 7.658

Review 8.  Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs).

Authors:  Karsten Brand
Journal:  Curr Gene Ther       Date:  2002-05       Impact factor: 4.391

9.  Stress-related modulation of matrix metalloproteinase expression.

Authors:  Eric V Yang; Cynthia M Bane; Robert C MacCallum; Janice K Kiecolt-Glaser; William B Malarkey; Ronald Glaser
Journal:  J Neuroimmunol       Date:  2002-12       Impact factor: 3.478

10.  Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus.

Authors:  Jennifer Zechel; Harsh Gohil; W David Lust; Alan Cohen
Journal:  J Neurosci Res       Date:  2002-09-01       Impact factor: 4.164

View more
  71 in total

1.  TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.

Authors:  Sergio Duarte; Takashi Hamada; Naohisa Kuriyama; Ronald W Busuttil; Ana J Coito
Journal:  Hepatology       Date:  2012-07-11       Impact factor: 17.425

Review 2.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Protective effect of carbamazepine on kainic acid-induced neuronal cell death through activation of signal transducer and activator of transcription-3.

Authors:  Hae Jeong Park; Su Kang Kim; Joo-Ho Chung; Jong Woo Kim
Journal:  J Mol Neurosci       Date:  2012-07-08       Impact factor: 3.444

4.  CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1.

Authors:  Jerel Fields; Jessica Gardner-Mercer; Kathleen Borgmann; Ian Clark; Anuja Ghorpade
Journal:  J Neurochem       Date:  2011-03-14       Impact factor: 5.372

5.  Human aqueous humor levels of transforming growth factor-β2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases.

Authors:  Yan Jia; Yu Yue; Dan-Ning Hu; Ji-Li Chen; Ji-Bo Zhou
Journal:  Biomed Rep       Date:  2017-10-20

6.  An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines.

Authors:  I Dafnis; A K Tzinia; E C Tsilibary; V I Zannis; A Chroni
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

7.  Newborn screening for autism: in search of candidate biomarkers.

Authors:  Gerald J Mizejewski; Barbara Lindau-Shepard; Kenneth A Pass
Journal:  Biomark Med       Date:  2013-04       Impact factor: 2.851

8.  Interferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients.

Authors:  Antonios Katsounas; Joseph J Rasimas; Joerg F Schlaak; Richard A Lempicki; Donald L Rosenstein; Shyam Kottilil
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

9.  Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion Cells.

Authors:  Shaoqing He; Yong H Park; Thomas Yorio; Raghu R Krishnamoorthy
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09-01       Impact factor: 4.799

10.  CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia.

Authors:  Sugato Banerjee; Timothy F Walseth; Kathleen Borgmann; Li Wu; Keshore R Bidasee; Mathur S Kannan; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.